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ABSTRACT
Introduction: Psoriasis patients demonstrate
high interest in the role of diet on their skin
condition. However, data are lacking to describe
dietary interventions among psoriasis patients
and associated outcomes. This study aims to
identify common dietary habits, interventions
and perceptions among patients with psoriasis,
and to examine patient-reported skin outcomes
in response to these interventions.
Methods: We administered a 61-question sur-
vey to the National Psoriasis Foundation mem-
bership asking psoriasis patients about dietary
habits, modifications, skin responses, and
perceptions.
Results: A total of 1206 psoriasis patients
responded to the survey. Compared to age- and
sex-matched controls, psoriasis patients
consumed significantly less sugar, whole grain
fiber, dairy, and calcium (p\0.001), while con-
suming more fruits, vegetables, and legumes
(p\0.01). Eighty-six percent of respondents
reported use of a dietary modification. The per-
centage of patients reporting skin improvement
was greatest after reducing alcohol (53.8%), glu-
ten (53.4%), nightshades (52.1%), and after
adding fish oil/omega-3 (44.6%), vegeta-
bles (42.5%), and oral vitamin D (41%). Specific
dietswith themost patients reporting a favorable
skin responsewere Pagano (72.2%), vegan (70%),
and Paleolithic (68.9%). Additionally, 41.8% of
psoriasis respondents reported that amotivation
for attempting dietary changes was to improve
overall health.
Conclusion: This national survey is among the
first to report the dietary behaviors of patients
with psoriasis. The data provided from this large
cohort may benefit patients and clinicians as
they discuss the role of diet in managing both
psoriasis and associated cardiometabolic
comorbidities.
Keywords: Diet; Nutrition; Psoriasis; Psoriatic
arthritis; Triggers
INTRODUCTION
Psoriasis is a chronic immune-mediated disease
affecting 3–4% of the world population [1]. The
innate and adaptive immune systems are
Enhanced content To view enhanced content for this
article go to http://www.medengine.com/Redeem/
E128F060166C6BD7.
Electronic supplementary material The online
version of this article (doi:10.1007/s13555-017-0183-4)
contains supplementary material, which is available to
authorized users.
L. Afifi (&)  M. J. Danesh  K. M. Lee 
K. Beroukhim  B. Farahnik  R. S. Ahn  D. Yan 
R. K. Singh  M. Nakamura  J. Koo  W. Liao
Department of Dermatology, University of
California, San Francisco, San Francisco, CA, USA
e-mail: ladiafifi@gmail.com
Dermatol Ther (Heidelb) (2017) 7:227–242
DOI 10.1007/s13555-017-0183-4
thought to be responsible for psoriasis patho-
genesis, while well-recognized environmental
factors like smoking and emotional stress can
modify disease severity [2].
One environmental factor of high interest to
patients is the influence of diet on psoriasis.
Although the popular literature contains many
dietary recommendations for psoriasis, the sci-
entific literature is limited, especially among
randomized controlled trials (RCT). The stron-
gest scientific evidence exists for weight loss,
particularly among obese psoriatic patients
[3–10], and for gluten-free diets (GFD), which
have been reported to improve psoriasis in a
subset of patients with celiac-specific antibodies
[11–15]. Moreover, there is an absence of studies
describing the effects of popular dietary rec-
ommendations and regimens, such as a Pale-
olithic diet or a vegetarian diet. The limited
literature on diet and psoriasis represents an
important knowledge gap that makes it difficult
for patients and clinicians to discuss this topic.
Psoriasis is increasingly being recognized as a
systemic inflammatory condition as a result of
an emerging and rapidly growing body of evi-
dence supporting an association between pso-
riasis and cardiometabolic disease as well as
various other comorbidities [16]. As a result, a
greater need to provide comprehensive care to
patients with psoriasis has been recently been
proposed and encouraged [17]. Thus, engaging
in dietary recommendations and management
options with psoriatic patients aligns with this
shift towards comprehensive care for not only
control and prevention of their skin disease but
also for managing their overall and long-term
health.
In order to understand the role of dietary
modifications in the management of psoriasis,
a survey of psoriasis patients with the follow-
ing objectives was conducted: (1) to quantify
nutrient intake in psoriasis patients compared
to population controls; (2) to identify popular
dietary interventions among psoriasis patients
and the influence of those interventions on
psoriasis improvement based on patient-re-
ported skin responses; and (3) to understand
the attitudes and perceptions of psoriasis
patients regarding the role of diet in managing
psoriasis.
METHODS
Study Design and Subjects
We performed an exploratory survey study of
psoriasis patients via email distribution to the
National Psoriasis Foundation (NPF) list-serve
from August 2014 to January 2015 (survey pro-
vided in Appendix 1 within the supplemental
material). The NPF was used for recruitment due
to their large network and well-engaged, moti-
vated patient community with a convenient
means to access this community through a
periodic newsletter. A response rate was calcu-
lated based on the ‘‘click-through rate,’’ which
reflects the number of recipients who opened
the survey. The survey contained 61 questions,
was voluntary and no incentives were offered.
The first 30 questions were from the 2009–2010
National Health and Nutrition Examination
Survey (NHANES) dietary screening question-
naire, which assesses nutrient intake in several
food categories and has undergone validation
using 24-h dietary recall forms [18]. The last 31
questions focused on patient-reported skin
responses to dietary changes, patients’ attitudes
regarding diet as a management strategy for
their psoriasis, and participant demographics.
The latter 31 questions were developed based on
topics of interest found in NPF discussion for-
ums, popular literature, patient discussion and a
review of the scientific literature. The Institu-
tional Review Board (IRB) at the University of
California, San Francisco (UCSF), approved this
study. All procedures followed were in accor-
dance with the ethical standards of the UCSF
IRB and with the Helsinki Declaration of 1964,
as revised in 2013. Informed consent was
obtained from all patients for being included in
the study. Study data were collected and man-
aged using REDcap (Research Electronic Data
Capture) electronic data capture tools hosted at
UCSF [19]. Data were exported from REDcap
and numerically coded for statistical analysis.
Statistical Analysis
All dietary changes, attitude/perception, and
demographic data were compiled and
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frequencies reported. A geographical informa-
tion system plot of patients overlaid over the
contiguous United States (U.S.) was created with
the self-reported zip codes from each partici-
pant and created using the maps package in R
3.2.2 [20, 21]. Data processing and scoring of
nutrient intake was performed using NHANES
guidelines [22]. Population control data from
the NHANES 2009–2010 dataset was matched to
our psoriasis cohort based on age and gender.
Differences in relative daily consumption of key
dietary components were identified using a
Mann–Whitney U Test in SAS, with statistical
significance set to p = 0.05.
Patient-perceived skin responses to dietary
changes were rated on a Likert scale consisting
of: Worsened, No Change, Improved, and Fully
Clear. A positive response was defined as par-
ticipants reporting Fully Clear or Improved,
while a negative response was defined as No
Change or Worsened. We performed associa-
tion testing between demographic variables
(race, sex, age, age of onset, education, income
level, self-reported psoriasis severity off treat-
ment, self-reported BSA off treatment, psoriatic
arthritis status, family history, BMI, celiac dis-
ease status, urban/rural living environment)
and patient-perceived favorable responses to
dietary changes. After performing univariate
logistic regression (see Appendix 2 in the sup-
plementary material) to identify individual
demographic variables associated with a
patient-reported favorable response to dietary
changes (p\0.05), we then used multivariate
logistic regression to evaluate for independent
effects. We report variables from multivariate
analysis with p\0.05. Odds ratios (OR) and
their corresponding 95% confidence intervals
were calculated. A similar analysis was con-
ducted to evaluate the association of demo-
graphic variables with dietary perceptions and
attitudes. A two-step cluster analysis using SPSS
v.23.0 (IBM, Armonk, NY, USA) was also per-
formed, grouping respondents based on dietary
behavior/experience and comparing the influ-
ence of various demographic factors and dietary
perceptions. One-way analysis of variance was
performed to compare the continuous variables
of age, weight, and age of onset by the two
clusters. The remaining analyses used
Chi-squared tests (cluster analysis data can be
found in Appendix 3 within the supplementary
material).
RESULTS
Demographics
Overall, 1206 psoriasis patients responded to the
survey with a 60% response rate. The demo-
graphic characteristics of the patient population
are shown inTable 1. Themean age of the sample
population was 50.4, and 73% of respondents
were female. The sample population represented
all levels of psoriasis severity based on self-re-
ported severity scores: 20.9% with mild disease,
42.2% with moderate disease, and 36.9% with
severe disease. Self-reported body surface area
(BSA) involvement without treatment was well
distributed, with 7.8% reporting barely any or
very little BSA, 29.6% reporting\5% BSA, 24.9%
reporting 5–10% BSA, 19.1% reporting 11–20%
BSA and 18.6% reporting[20% BSA. Concomi-
tant psoriatic arthritis was self-reported in 43.9%
of respondents. The sample population was pre-
dominantly white (87.2%) and lived in an urban
setting (79%). A geographic map showing the
location of respondents demonstrates represen-
tation across the U.S. (Fig. 1).
Daily Consumption in Psoriasis
versus Control Group
Compared to the 2009–2010 NHANES controls,
psoriasis patients in this study demonstrated a
significant difference in daily consumption of
specific nutrients based on the food frequency
questionnaire (Table 2). On average, respon-
dents reported less daily intake of sugar, whole
grain fiber, dairy products, and calcium
(p\0.001), and higher daily intake of fruits/
vegetables/legumes (p = 0.007).
Perceived Dietary Triggers and Helpful
Additives
About 37% of respondents reported that they
did not recognize any dietary triggers which
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may worsen their psoriasis or left the survey
field blank (Fig. 2). Among respondents, the
most common reported triggers were sugar
(13.8%), alcohol (13.6%), tomato (7.4%), gluten
(7.2%), and dairy (6%). Less commonly reported
triggers (2–5% of reported triggers) included
meat, processed foods, soda, bread, beer, wine,
eggs, and spicy foods.
Respondents also reported dietary items that
may improve psoriasis. This included con-
sumption of dietary supplements (35.1%), veg-
etables (26.5%), fruits (21.8%), water (11.2%),
and fish (9.2%) (Fig. 3).
Dietary Modifications and Reported
Outcomes
Among respondents, 1037 reported a trial of
avoiding or reducing specific foods and 988
noted a trial of adding certain foods; a complete
list is shown in Table 3. The most common
dietary reductions associated with patient-re-
ported positive skin response were alcohol
(53.8%), gluten (53.4%), nightshades (52.1%),
junk foods (50%), and white flour products
(49.9%). A positive skin response was also
reported by respondents when adding fish oil/
omega-3 (44.6%), vegetables (42.5%), oral vita-
min D (41%), probiotics (40.6%), organic foods
(38.4%), and fruits (34.6%) (Table 4).
Among all respondents, 481 respondents
(40%) reported trying a special diet for their pso-
riasis, the most common being gluten-free
(35.6%), low carbohydrate–high protein (16.6%),
and Paleolithic (11.6%) diets (Table 5). The three
diets with the highest patient-reported positive
response were the Pagano, vegan, and Paleolithic
diets. Other diets that patients reported to
improve their psoriasis included gluten-free, low
carbohydrate–high protein, Mediterranean and
vegetarian diets. Across all special diets, 69% of
patients reported weight loss.
Demographic Factors Associated
with Favorable Dietary Outcomes
We examined whether demographic factors
were associated with patient-reported favorable
dietary responses (Table 6). We found that
Table 1 Demographic characteristics of survey
respondents
Variable Value
Age, mean (SD) 50.4 (14.3)
Sex, n (%)
Male 322 (26.7)
Female 884 (73.3)
Average age at onset of psoriasis, mean (SD) 27.2 (17.2)
Severity of skin condition
(without treatment), n (%)
Mild 252 (20.9)
Moderate 509 (42.2)
Severe 444 (36.9)
Body surface area (without treatment), n (%)
Barely any or very little 94 (7.8)
\5% body surface 357 (29.6)
5–10% body surface 300 (24.9)
11–20% body surface 230 (19.1)
[20% body surface 224 (18.6)
Presence of psoriatic arthritis 529 (43.9)
Family history of skin condition, n (%) 581 (48.3)
Average BMI, mean (SD) 28.4 (7.4)
Underweight (\18.5), n (%) 35 (2.9)
Normal (18.5–24.9), n (%) 403 (33.6)
Overweight (25–29.9), n (%) 360 (30.3)
Obese 30?, n (%) 396 (32.8)
Race, n (%)
White 1066 (87.2)
Asian/Pacific Islander 60 (5)
Hispanic 47 (3.9)
Native American 16 (1.3)
African American 8 (0.7)
Other 25 (2.1)
Highest level of education, n (%)
Less than high school 14 (1.2)
High school graduate 207 (17.3)
Undergraduate 371 (30.9)
Graduate/professional degree 608 (50.7)
Area in which you live, n (%)
Urban/suburban 945 (79)
Rural 251 (21)
Average annual household income, n (%)
\$20,000 88 (7.4)
$20,000–$40,000 151 (12.7)
$40,001–$60,000 168 (14.1)
$60,001–$100,000 242 (20.4)
[$100,000 298 (25.1)
Prefer not to say 242 (20.4)
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younger age was associated with greater repor-
ted positive response to avoidance of red meat,
high fat foods, sodium, white flour, and alco-
hol, with an effect size of 1–3% decrease in odds
per additional year of age. Non-white race was
associated with a greater patient-reported
favorable response to avoidance of red meat,
pork, high fat foods, sodium, and addition of
fruits, with non-white race increasing the odds
of patient-reported positive response by
approximately two- to fourfold. Patients who
reported having severe psoriasis reported
responding better to avoidance of caffeine
Fig. 1 Geographic location of psoriasis survey respondents
Table 2 Relative daily consumption of key dietary components in psoriasis versus control groups
Dietary intake Psoriasis data (n5 1017)
Mean – SD
NHANES data
Mean – SD (n)
p value
Daily added sugar (tsp.) 10.6 ± 7.64 15.3 ± 10.7 (2815) \0.0001
Daily whole grain (oz.) 0.704 ± 1.17 0.846 ± 1.35 (2842) \0.0001
Daily fiber (g) 13.7 ± 5.69 14.5 ± 5.64 (2609) 0.0002
Daily dairy (cup) 1.25 ± 0.891 1.45 ± 0.91 (2847) \0.0001
Daily calcium (mg) 741 ± 397 827 ± 423 (2609) \0.0001
Daily fruit/vegetable/legume (cup) 2.58 ± 0.957 2.51 ± 1.08 (2724) 0.0070
Fig. 2 Reported dietary triggers that worsen psoriasis.
Only responses [5% listed. Less commonly reported
triggers (2–5%) included meat, processed foods, soda,
bread, beer, wine, eggs, and spicy foods
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(OR = 2.3), while those with celiac disease
reported faring better with avoidance of white
flour (OR = 4.3).
Attitudes and Perceptions About Diet
Attitudes surrounding diet as a management
strategy for their disease are reported in Table 7.
Fig. 3 Reported dietary additions that Improve psoriasis.
Only responses[5% listed. *Common dietary supplements
reported include: vitamin D, fish oil/omega-3, probiotics,
vitamin B, vitamin E, vitamin C, vitamin A, and turmeric
capsules
Table 3 Reported dietary modifications in psoriasis
patients
Dietary removals Dietary additions
% of respondents reporting
trial of dietary item removal
(n = 1037)
% of respondents
reporting dietary item
addition (n = 988)
Junk foodsa: 66.7%
White flour products: 55.7%
High fat foods: 50.4%
Red meat: 49.5%
Alcohol: 45%
Gluten: 44.6%
Dairy: 41.3%
Tobacco: 36.1%
Sodium/salt: 34.5%
Nightshadesb: 28.8%
Caffeine: 27%
Pork: 26.8%
Shellfish: 18%
Other: 9.2%
Vegetables: 58.8%
Fish oil/omega-3: 56.8%
Oral vitamin D: 55.6%
Fruits: 54.7%
Probiotics: 44.4%
Organic foods: 39.6%
Other: 9.2%
a Junk foods: candy and pastries, chocolate, french fries,
potato chips, sweets
b Nightshades: tomatoes, eggplant, peppers, paprika, white
potatoes
Table 4 Outcomes to dietary interventions in psoriasis
patients
Dietary removals Dietary additions
Respondents reporting
full clearance or
improvement of psoriasis
with removal of the
following from their diet
(%)
Respondents reporting full
clearance or improvement
of psoriasis after addition
of the following to their
diet (%)
Alcohol: 251 of 462(53.8%)
Gluten: 247 of 459 (53.4%)
Nightshadesa: 156 of 297
(52.1%)
Junk foodsb: 346 of 687
(50%)
White flour products: 288
of 573 (49.9%)
Dairy: 204 of 424 (47.7%)
Shellfish: 73 of 186 (39%)
High fat foods: 193 of 519
(36.9%)
Caffeine: 102 of 275
(36.4%)
Pork: 99 of 276 (35.6%)
Tobacco: 131 of 370 (35%)
Red meat: 156 of 509
(30.4%)
Sodium/salt: 76 of 356
(21.2%)
Fish oil/omega-3: 250 of
556 (44.6%)
Vegetables: 247 of 575
(42.5%)
Oral vitamin D: 216 of 545
(41%)
Probiotics: 178 of 434
(40.6%)
Organic foods: 150 of 388
(38.4%)
Fruits: 187 of 534 (34.6%)
a Nightshades: tomatoes, eggplant, peppers, paprika, white
potatoes
b Junk Foods: candy and pastries, chocolate, french fries,
potato chips, and sweets
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The majority of respondents were not sure how
diet affected their skin (43.2%); however, 16.7%
felt diet was significantly helping their skin and
17.4% felt diet was slightly helping their skin.
Of note, 57.9% of patients found it very or
somewhat difficult to follow a special diet,
17.4% of patients found it very time consum-
ing, and 11.4% found it very expensive to fol-
low a special diet.
Motivation for using diet to improve psoria-
sis varied among patients. The most commonly
reported reasons include: diet may improve
other health problems (41.8%), diet is a natural
method (32.2%), and previous treatments failed
(26.5%). Although 86% of respondents had
tried a dietary modification, and 88.8% found it
very or somewhat important that physicians
discuss with patients the role of diet in
managing skin disease, only 30.7% had actually
discussed dietary changes with a dermatologist.
Patients were asked to rate the importance of
diet compared to other interventions or treat-
ments for management of their psoriasis: 41.5%
of respondents rated diet to be more important
than over-the-counter medications; diet was
also rated as more important than comple-
mentary medications in 31.9%, prescription
medications in 31%, exercise in 21.3%, and
stress reduction in 8.9%.
Demographic Factors Associated
with Perceptions and Attitudes About Diet
Similarly, we performed an analysis examining
demographic predictors for perceptions regard-
ing dietary management of psoriasis (Supple-
mentary Table 1). The belief that ‘‘diet plays an
important role in managing psoriasis’’ was
associated with younger age and patients
reporting less severe psoriasis. The belief that
‘‘following a specific diet is burdensome’’ was
associated with younger age, female gender,
and those with psoriatic arthritis. Interestingly,
respondents who reported discussing dietary
changes with a dermatologist were more likely
to report having severe psoriasis or higher BSA
involvement.
Cluster Analysis
Cluster analysis based on dietary behavior
identified two groups: Cluster 1 was highly
active in their dietary modifications and fre-
quently engaged in avoiding red meat, pork,
sodium, high fat foods, caffeine, alcohol and
tobacco and were more likely to add fruits,
vegetables, organic foods, probiotics, fish and
vitamin D; Cluster 2 was a less active
dietary-modifying group and instead selectively
avoided shellfish, gluten, white flour and junk
food. Examination of variations in demographic
factors between the two groups found signifi-
cant differences, whereby Cluster 2 was younger
(p\0.001), had an earlier mean age of onset
(p = 0.012), weighed less (p = 0.011), had a
higher prevalence of celiac disease (p = 0.017),
and had greater racial diversity (p\0.001).
Cluster 2 was also significantly more likely to
discuss with their dermatologist regarding diet-
ary modifications (p\0.001), and believed that
Table 5 Frequencies of special diets used for psoriasis and
outcomes
Special diets
% of respondents
reporting trial of special
diet (n5 481)
Respondents reporting full
clearance or improvement
of psoriasis after special diet
(%)
Gluten-free: 35.6%
Low carbohydrate–high
protein: 16.6%
Paleolithic: 11.6%
Vegetarian: 9.7%
Mediterranean: 5.8%
Vegan: 5.4%
Other: 9.7%
Pagano diet (13 of 18, 72.2%)
Vegan diet (20 of 29, 70%)
Paleolithic diet (42 of 62,
68.9%)
Gluten-free diet (101 of 191,
52.9%)
Low carbohydrate–high
protein diet (45 of 89,
51.7%)
Mediterranean diet (15 of 31,
48.4%)
Vegetarian diet (21 of 52,
40.4%).
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speaking with a dermatologist regarding diet is
particularly important (p\0.001). The groups
did not significantly differ in sex, education
level, living environment, income level, and
prevalence of family history of psoriasis.
DISCUSSION
Relative Daily Consumption in Psoriasis
vs. Control Group
Compared to the NHANES 2009–2010 control
dataset, the psoriasis cohort presented here con-
sumed less sugar, whole grain fiber, dairy, and
calcium, while consuming more fruits and veg-
etables. These differences may be attributable to
psoriasis patients following recommendations in
the popular literature, which suggests that sugar,
gluten, and dairy may serve as triggers, while
fruits and vegetables have health benefits. Indi-
viduals participating in our surveymay have had
greater interest in the topic of diet and therefore
engaged in these dietary changes. This is sup-
ported by 86%of respondents reporting a history
of using some form of dietary modification, and
almost half of respondents reported reducing
gluten. The lower sugar intake observed in our
cohort is consistent with findings of another
study using the NHANES data where psoriasis
patients reported decreased sugar intake com-
pared to healthy controls [23].
Reported Triggers and Helpful Additives
The most common psoriasis triggers reported by
respondents were sugar, alcohol, nightshades,
and gluten. The mechanism of how each of
these triggers may induce or exacerbate psoria-
sis is unclear. However, prior studies have
Table 6 Demographic factors associated with response to dietary change
Intervention Multivariate analysis
Variable p value OR (95% CI)
Avoidance of red meat Age (increasing) 0.04 0.98 (0.97–0.99)a
Race (white) 0.0084 0.46 (0.26–0.82)b
Avoidance of pork Race (white) 0.03 0.45 (0.22–0.92)
Avoidance of high fat foods Age (increasing) 0.03 0.99 (0.97–1.00)
Race (white) 0.03 0.53 (0.30–0.93)
Avoidance of sodium Age (increasing) 0.0008 0.97 (0.95–0.99)
Race (white) 0.03 0.45 (0.22–0.93)
Avoidance of white flour Age (increasing) 0.03 0.98 (0.96–0.998)
Positive of celiac disease 0.005 4.3 (1.5–11.9)c
Avoidance of caffeine Severe psoriasis 0.004 2.30 (1.30–4.00)d
Avoidance of alcohol Age 0.0001 0.97 (0.95–0.98)
Addition of fruits Race (white) \0.0001 0.22 (0.11–0.45)
Positive family history of psoriasis 0.04 1.76 (1.03–3.0)e
a OR of patient-perceived favorable response with increasing age
b OR of patient-perceived favorable response in white race vs. non-white race
c OR of patient-perceived favorable response in individuals with celiac disease vs. individuals without celiac disease
d OR of patient-perceived favorable response in severe psoriasis vs. mild/moderate psoriasis
e OR of patient-perceived favorable response in patients with positive family history vs. negative family history of psoriasis
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implicated these dietary components in causing
alterations in the intestinal microbiome com-
position, irritating the intestinal lining, and
upregulation of the immune system. Evidence
suggests that dietary simple sugars lead to
dysbiosis of the gut microbiome favoring inju-
rious bacterial taxa and an increase in inflam-
matory cytokines [24–35]. Alternatively,
complex carbohydrates with high fiber, such as
those found in fruits and vegetables, have been
found to have an opposite effect on the gut
microbiome and reduce inflammation [36–43].
An increase in inflammatory cytokines may
also explain the link between alcohol and psori-
asis. Excessive alcohol intake has been associated
with the development of psoriasis and is corre-
lated with psoriasis severity [44, 45]. Proposed
mechanisms for the interaction of alcohol in
psoriasis include enhancement of mito-
gen-driven lymphocyte proliferation and upreg-
ulation of pro-inflammatory cytokines [46, 47].
In addition to upregulation of inflammatory
cytokines, factors proposed to disturb the
intestinal lining, such as nightshades, may also
contribute to the exacerbation of immune-re-
lated disorders. Nightshades are part of a plant
family called Solanaceae, which includes
tomato, potato, eggplant, tobacco, pepper, and
petunia, and have been found to affect diges-
tion and absorption of nutrients in humans and
animals [48]. Nightshades produce alkaloids,
which have been shown to adversely affect the
mammalian intestine and to aggravate inflam-
matory bowel disease (a common comorbidity
in psoriasis patients) in the murine model [49].
Several studies have documented celiac dis-
ease and psoriasis coexistence and the
improvement of psoriatic lesions after starting a
GFD [11, 12, 50]. The benefit of GFD has been
shown to extend to patients who are antigliadin
antibody-positive but without clinical and his-
tological markers of celiac disease [13–15].
These findings explain both a common trigger
among respondents in this study being gluten
and a patient-reported improvement of their
psoriasis following a GFD.
While some dietary elements are posited to
trigger psoriasis, other foods have been sug-
gested to improve disease symptoms. The most
commonly reported include fish oil/omega-3
polyunsaturated fatty acids (PUFAs), fruits and
vegetables, vitamin D supplementation, and
probiotics. A systematic review identified 15
trials evaluating fish oil supplementation and
found an overall moderate reduction in
Table 7 Attitudes surrounding diet as management
strategy for psoriasis
Questions and responses n (%)
Currently, what role is diet playing in managing your skin
condition?
Skin condition completely controlled by diet 27 (2.2)
Diet is helping significantly with skin
condition
201 (16.7)
Diet is helping slightly with skin condition 210 (17.4)
Diet has no effect on skin condition 200 (16.6)
Not sure how diet affects skin condition 521 (43.2)
Other 47 (3.9)
How difficult/burdensome is it to follow a special diet?
Very difficult 226 (18.7)
Somewhat difficult 473 (39.2)
Not difficult 324 (26.9)
Not applicable 183 (15.2)
What difficulties did you encounter in modifying your
diet?
Will power/too limiting 237 (36.5)
Time/inconvenience 113 (17.4)
Family/social pressures 88 (13.6)
Dining out/travel 88 (13.6)
Affordability 74 (11.4)
Access 48 (7.4)
How important is it that physicians discuss with patients
the role of diet in managing skin disease?
Very important 781 (64.8)
Somewhat important 290 (24)
Minimally important 102 (8.5)
Not important at all 33 (2.7)
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psoriasis symptoms [51]. There was moderate
evidence of benefit for the use of fish oil sup-
plements in psoriasis among twelve trials (six
controlled, six uncontrolled) [52–63] and three
trials (two controlled, one uncontrolled) show-
ing no benefit [64–66]. PUFAs are thought to
reduce the conversion of free arachadonic acids
to leukotriene B4, which is elevated in psoriatic
lesions [67, 68]. Additionally, PUFAs reduce the
production of tumor necrosis factor (TNF)-al-
pha, interleukin (IL)-1b, and IL-1a in healthy
adults and rheumatoid arthritis patients
[69–72].
Previous cross-sectional, case–control, and
case studies have suggested an inverse relation-
ship between psoriasis and fruits and veg-
etable intake [73–76]. Fruits and
vegetables provide a wealth of antioxidants such
as carotenoids, flavenoids, vitamins, and miner-
als that have been inversely correlated with
TNF-alpha, C-reactive protein (CRP), and IL-6
[77–79]. Vitamin D may have antiproliferative
and immunomodulatory effects. Among clinical
studies, data on vitamin D supplementation
have been equivocal. A systematic review iden-
tified significant improvements in psoriasis area
severity index (PASI) score followingoral vitamin
D supplementation in eight uncontrolled stud-
ies; however, one RCT demonstrated only a
slight, statistically insignificant improvement
[51, 80–87]. Probiotics aim to restore balance to
the host gut microbiome; however, current evi-
dence regarding the role of probiotics in psoriasis
is limited. An RCT of oral probiotics in spondy-
loarthritis patients, including those with psoria-
sis and psoriatic arthritis, found no significant
change in disease severity [88]. The true effect of
probiotics may be influenced by factors such as
probiotic composition, dose, route of adminis-
tration and interaction with dietary habits.
Special Diets
Survey respondents self-reported appreciable
symptom improvement with Mediterranean,
Pagano, Paleolithic, vegan, gluten-free, and low
carbohydrate–high protein diets. A case report
documented significant improvement in psori-
asis lesions in all five patients following a
6-month diet regimen analogous to the Pagano
diet, which entails an increase in fruits and
vegetables and a decrease in nightshades and
junk food among various other recommenda-
tions [75, 89]. An observational study found
improvement in a subset of psoriasis patients
following a 2-week fast and a subsequent 3-week
vegetarian diet [90]. Additionally, in patients
with rheumatoid arthritis and atopic dermatitis,
vegan and vegetarian diets have been shown to
alleviate symptoms and promote weight loss,
which may decrease adipocyte-mediated
inflammation [91, 92]. Similarly, many respon-
dents reported concomitant weight loss with a
trial of special diets, possibly contributing to the
reported benefits. A case–control study of
mild-to-severe psoriasis found extra virgin olive
oil and fish oil, typical components of a
Mediterranean diet, to decrease PASI scores and
CRP levels [93]. In addition to improvement in
psoriatic lesions, many of these diets are also
advantageous in improving the cardiometabolic
profile of patients with psoriasis, as many
respondents reported a benefit of overall health
as the motivation behind attempting dietary
changes. Evidence suggests that the Mediter-
ranean and Paleolithic diets can reduce the risk
of cardiometabolic comorbidities in psoriasis,
which are a predominant cause of reduced life
expectancy and an important aspect of disease
management [94–97].
Demographic Variables Associated
with Dietary Changes
Favorable dietary changes were more com-
monly reported in respondents who were
younger, non-white, and positive for celiac
disease. Chronic inflammation has been shown
to be a characteristic of an aging immune sys-
tem; specifically, evidence has shown an
increase in cytokines and inflammatory markers
in older compared to younger adults [98–101].
One can speculate that the possible increase in
baseline inflammation in older subjects could
dampen the anti-inflammatory influences of
dietary changes.
The association of non-white race with a
favorable response to dietary changes was
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intriguing. The effect of race could relate to
genetics or the environment or both. Several
studies have reported racial and ethnic varia-
tions in genes implicated in the pathogenesis of
psoriasis [102]. These differences in immuno-
logical-related genes may result in variations in
response to environmental insults such as diet.
Removal of gluten from the diet in patients
with celiac disease had a beneficial effect in our
survey respondents, which parallels findings
from other studies [11, 50]. Interestingly, celiac
patients in our study tended to rank diet as
more important for controlling their psoriasis
than prescription, over-the-counter, and com-
plementary medications.
Demographic Variables Associated
with Attitudes and Perceptions
Managing psoriasis using dietary interventions
was viewed as more important by respondents
who were younger and those self-reporting
mild/moderate disease activity. However,
respondents who report having severe psoriasis
were more prone to discuss dietary changes
with their dermatologist, likely reflecting
information-seeking behavior due to the sever-
ity of their disease. Difficulty with following a
diet was more likely to be reported by respon-
dents who were younger, female and with pso-
riatic arthritis. Factors underlying this
association include the cost and labor involved
in purchasing and preparing healthier meals, as
well as the physical burden of cooking among
those with psoriatic arthritis.
Cluster Analysis
Results from the cluster analysis identified two
distinct clusters of patients based on dietary
behavior. Cluster 1 was composed of older
patients with higher BMI who engaged in broad
dietary changes aligned with achieving global
health and minimizing cardiovascular and/or
cancer risk (e.g., avoidance of red meat, pork,
sodium, high fat foods, caffeine, alcohol and
tobacco and the addition of fruits, vegetables or-
ganic foods, probiotics, fish and vitamin D).
Cluster 2 was composed of younger patients who
selectively avoided or minimized specific foods
from their diet (e.g., gluten, white flour, junk
food, and shellfish). These patientsmay approach
dietary change with the intention of reducing
dietary triggers of their psoriasis and may be less
concerned with diets involving improved global
health and cardiovascular risk. Given the
increased cardiovascular risk in patients with
psoriasis, all patients should be counseled on the
importance of sustaining a healthy overall diet in
light of their increased risk for cardiovascular
disease, while also considering dietary habits that
may improve their skin condition.
Limitations
Study limitations include the potential for
responder bias and a predominance of female
gender, white race, respondents with moderate
to severe disease, and urban-living respondents,
restricting generalizability. Time lapse may be a
concern in that the NPF psoriasis data were
collected in 2014 while control data were col-
lected in 2010. Substantial changes in diet have
not been reported from the 2010 to 2014
NHANES dataset, suggesting a valid comparison
of the two nutrition datasets. An article search
also did not identify any dietary trends or
changes based on NHANES datasets from 2010
to 2014.
Additionally, limitations of the survey
instrument include lack of validation for part
two of the survey. Duration of dietary modifi-
cations was not assessed, neither were the
quantitative reduction nor addition of the
specific dietary modification, all of which may
be contributing factors to the variation in skin
responses reported among respondents. How-
ever, the study purpose was not to provide evi-
dence-based guidelines, rather the information
presented is primarily to understand the role of
diet in managing psoriasis among a large cohort
of psoriasis patients.
CONCLUSIONS
This is the first study to better understand the
patient experience regarding the role of diet in
the management of psoriasis. Importantly, the
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majority of respondents report the motivation
for trialing dietary modifications is to improve
their overall health. Therefore, when discussing
with patients interested in dietary management
of their psoriasis, physicians can use this
opportunity to encourage dietary changes with
the intention of benefiting both psoriatic
lesions and the cardiometabolic risk factors
associated with psoriasis. Future prospective
RCTs are needed to identify and validate opti-
mal dietary interventions for psoriasis as well as
the length of intervention needed to yield
results.
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